214 related articles for article (PubMed ID: 15735033)
1. Mitotic arrest deficient 2 expression induces chemosensitization to a DNA-damaging agent, cisplatin, in nasopharyngeal carcinoma cells.
Cheung HW; Jin DY; Ling MT; Wong YC; Wang Q; Tsao SW; Wang X
Cancer Res; 2005 Feb; 65(4):1450-8. PubMed ID: 15735033
[TBL] [Abstract][Full Text] [Related]
2. Depression of MAD2 inhibits apoptosis of gastric cancer cells by upregulating Bcl-2 and interfering mitochondrion pathway.
Du Y; Yin F; Liu C; Hu S; Wang J; Xie H; Hong L; Fan D
Biochem Biophys Res Commun; 2006 Jul; 345(3):1092-8. PubMed ID: 16714000
[TBL] [Abstract][Full Text] [Related]
3. MAD2-induced sensitization to vincristine is associated with mitotic arrest and Raf/Bcl-2 phosphorylation in nasopharyngeal carcinoma cells.
Wang X; Jin DY; Wong HL; Feng H; Wong YC; Tsao SW
Oncogene; 2003 Jan; 22(1):109-16. PubMed ID: 12527913
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of differential sensitivity to cisplatin in nasopharyngeal carcinoma cells.
Wang X; Masters JR; Wong YC; Lo AK; Tsao SW
Anticancer Res; 2001; 21(1A):403-8. PubMed ID: 11299769
[TBL] [Abstract][Full Text] [Related]
5. MAD2 interacts with DNA repair proteins and negatively regulates DNA damage repair.
Fung MK; Han HY; Leung SC; Cheung HW; Cheung AL; Wong YC; Ling MT; Wang X
J Mol Biol; 2008 Aug; 381(1):24-34. PubMed ID: 18597777
[TBL] [Abstract][Full Text] [Related]
6. Role of MEK/ERK pathway in the MAD2-mediated cisplatin sensitivity in testicular germ cell tumour cells.
Fung MK; Cheung HW; Ling MT; Cheung AL; Wong YC; Wang X
Br J Cancer; 2006 Aug; 95(4):475-84. PubMed ID: 16880791
[TBL] [Abstract][Full Text] [Related]
7. MAD2DeltaC induces aneuploidy and promotes anchorage-independent growth in human prostate epithelial cells.
To-Ho KW; Cheung HW; Ling MT; Wong YC; Wang X
Oncogene; 2008 Jan; 27(3):347-57. PubMed ID: 17621272
[TBL] [Abstract][Full Text] [Related]
8. p31comet Induces cellular senescence through p21 accumulation and Mad2 disruption.
Yun M; Han YH; Yoon SH; Kim HY; Kim BY; Ju YJ; Kang CM; Jang SH; Chung HY; Lee SJ; Cho MH; Yoon G; Park GH; Kim SH; Lee KH
Mol Cancer Res; 2009 Mar; 7(3):371-82. PubMed ID: 19276188
[TBL] [Abstract][Full Text] [Related]
9. Requirement of a functional spindle checkpoint for arsenite-induced apoptosis.
Wu YC; Yen WY; Yih LH
J Cell Biochem; 2008 Oct; 105(3):678-87. PubMed ID: 18668508
[TBL] [Abstract][Full Text] [Related]
10. Weakened spindle checkpoint with reduced BubR1 expression in paclitaxel-resistant ovarian carcinoma cell line SKOV3-TR30.
Fu Y; Ye D; Chen H; Lu W; Ye F; Xie X
Gynecol Oncol; 2007 Apr; 105(1):66-73. PubMed ID: 17234259
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of mitotic cell death induced by chemotherapy-mediated G2 checkpoint abrogation.
Vogel C; Hager C; Bastians H
Cancer Res; 2007 Jan; 67(1):339-45. PubMed ID: 17210716
[TBL] [Abstract][Full Text] [Related]
12. Suppression of BCL-2 synergizes cisplatin sensitivity in nasopharyngeal carcinoma cells.
Low SY; Tan BS; Choo HL; Tiong KH; Khoo AS; Leong CO
Cancer Lett; 2012 Jan; 314(2):166-75. PubMed ID: 22033244
[TBL] [Abstract][Full Text] [Related]
13. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
Brenes O; Arce F; Gätjens-Boniche O; Díaz C
Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942
[TBL] [Abstract][Full Text] [Related]
14. Xrcc3 induces cisplatin resistance by stimulation of Rad51-related recombinational repair, S-phase checkpoint activation, and reduced apoptosis.
Xu ZY; Loignon M; Han FY; Panasci L; Aloyz R
J Pharmacol Exp Ther; 2005 Aug; 314(2):495-505. PubMed ID: 15843498
[TBL] [Abstract][Full Text] [Related]
15. KRIBB3, a novel microtubule inhibitor, induces mitotic arrest and apoptosis in human cancer cells.
Shin KD; Yoon YJ; Kang YR; Son KH; Kim HM; Kwon BM; Han DC
Biochem Pharmacol; 2008 Jan; 75(2):383-94. PubMed ID: 17915194
[TBL] [Abstract][Full Text] [Related]
16. Mad2beta, an alternative variant of Mad2 reducing mitotic arrest and apoptosis induced by adriamycin in gastric cancer cells.
Yin F; Du Y; Hu W; Qiao T; Ding J; Wu K; Liu Z; Fan D
Life Sci; 2006 Feb; 78(12):1277-86. PubMed ID: 16214181
[TBL] [Abstract][Full Text] [Related]
17. c-Myc-induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-kappa B activity in pancreatic cancer cells.
Biliran H; Banerjee S; Thakur A; Sarkar FH; Bollig A; Ahmed F; Wu J; Sun Y; Liao JD
Clin Cancer Res; 2007 May; 13(9):2811-21. PubMed ID: 17473215
[TBL] [Abstract][Full Text] [Related]
18. A requirement for breast-cancer-associated gene 1 (BRCA1) in the spindle checkpoint.
Wang RH; Yu H; Deng CX
Proc Natl Acad Sci U S A; 2004 Dec; 101(49):17108-13. PubMed ID: 15563594
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of glutathione synthesis reverses Bcl-2-mediated cisplatin resistance.
Rudin CM; Yang Z; Schumaker LM; VanderWeele DJ; Newkirk K; Egorin MJ; Zuhowski EG; Cullen KJ
Cancer Res; 2003 Jan; 63(2):312-8. PubMed ID: 12543781
[TBL] [Abstract][Full Text] [Related]
20. The involvement of XPC protein in the cisplatin DNA damaging treatment-mediated cellular response.
Wang G; Dombkowski A; Chuang L; Xu XX
Cell Res; 2004 Aug; 14(4):303-14. PubMed ID: 15353127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
